Research brokerages are projecting Nektar Therapeutics (NASDAQ:NKTR) to grow at an accelerated rate over the next 5 years. Wall Street analysts are looking for the company to grow -142.70% over the next year and -7.30% over the next five years.
Investors are usually striving to find that next big stock to add to the portfolio. With markets still riding high, investors will be closely watching the numbers as companies start reporting quarterly earnings results. Investors will also be keeping an eye on key economic data over the next few weeks. Many individual investors will approach the stock market from various angles. This may include following fundamental and technical information, and it may also include following analyst projections.
EPS measures what each share is worth and also indicates how much money their sharehoders would gain if the company was to pay out all of its profits. Earnings Per Share is computed by dividing the total profit by its total shares. Nektar Therapeutics’s trailing 12- months EPS is 4.89. Last year, their EPS growth was 188.30% and their EPS growth over the past five years was 21.50%.
Let’s start off by taking a look at how the stock has been performing recently. Over the past twelve months, Nektar Therapeutics (NASDAQ:NKTR)’s stock was -40.87%. Last week, it was -13.22%, -40.90% over the last quarter, and -55.55% for the past half-year.
Over the past 50 days, Nektar Therapeutics stock was -49.38% off of the high and 0.26% removed from the low. Their 52-Week High and Low are noted here. -68.29% (High), 24.90%, (Low).
Nektar Therapeutics (NASDAQ:NKTR)’s performance this year to date is -40.87%. The stock has performed -13.22% over the last seven days, -27.39% over the last thirty, and -40.90% over the last three months. Over the last six months, Nektar Therapeutics’s stock has been -55.55% and 16.53% for the year.
FUTURE GROWTH ESTIMATES AND RECOMMENDATIONS
Wall Street analysts are have a consensus analyst recommendation of 1.80 on the stock. This is based on a 1-5 scale where 1 represents a Strong Buy and 5 a Strong Sell. Brokerages covering the name have a $89.38 on the stock.
Investors might be looking to sharpen the gaze and focus on recent market action. As we move into the second part of the year, everyone will be watching to see which way the stock market momentum shifts. Many believe that the bulls are still charging while others feel like the bears may be waiting in the wings. There are various schools of thought when it comes to trading stocks. Investors may have to first asses their appetite for risk in order to start creating a solid investment plan.
The advice provided on this website is general advice only. It has been prepared without taking into account your objectives, financial situation or needs. Before acting on this advice you should consider the appropriateness of the advice, having regard to your own objectives, financial situation and needs. Where quoted, past performance is not indicative of future performance.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.